ArticleWorld journal of clinical cases2022

Vedolizumab in the treatment of immune checkpoint inhibitor-induced colitis: Two case reports.

Zhe Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.